Organization | Pediatric Cancer Foundation

Pediatric Cancer Foundation Report issue

Academic/Hospital Phase 1

Founded: Mamaroneck NY United States (1970)

Organization Overview

First Clinical Trial

2008

NCT00704054

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2013

Timeline

NOW

Now

Active Ingredients

Drugs in Phase 1 Trials (11)

cytarabine (cytosar-u) (1 trial)

doxorubicin (Doxil) (1 trial)

irinotecan (Camptosar) (1 trial)

pegaspargase (oncaspar) (1 trial)

ridaforolimus (1 trial)

sitagliptin (januvia) (2 trials)

sorafenib (nexavar) (1 trial)

temozolomide (temodar) (1 trial)

topotecan (hycamtin) (1 trial)

vincristine (oncovin) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Brain Neoplasms (Phase 1)

Leukemia (Phase 1)

Leukemia, Lymphoid (Phase 1)

Neoplasms (Phase 1)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 1)

Overview

Highest Phase: Phase 1
# of Trials: 4
# of Trial APIs: 11